DK1024815T3 - Farmaceutisk sammensætning til oral administrering af molekylært iod - Google Patents

Farmaceutisk sammensætning til oral administrering af molekylært iod

Info

Publication number
DK1024815T3
DK1024815T3 DK98954002T DK98954002T DK1024815T3 DK 1024815 T3 DK1024815 T3 DK 1024815T3 DK 98954002 T DK98954002 T DK 98954002T DK 98954002 T DK98954002 T DK 98954002T DK 1024815 T3 DK1024815 T3 DK 1024815T3
Authority
DK
Denmark
Prior art keywords
iodine
mammal
molecular iodine
molecular
pharmaceutical composition
Prior art date
Application number
DK98954002T
Other languages
Danish (da)
English (en)
Inventor
Yongjun Duan
John Hickey
Rick Panicucci
Jack Kessler
Original Assignee
Symbollon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbollon Corp filed Critical Symbollon Corp
Application granted granted Critical
Publication of DK1024815T3 publication Critical patent/DK1024815T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK98954002T 1997-10-29 1998-10-27 Farmaceutisk sammensætning til oral administrering af molekylært iod DK1024815T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/960,149 US5885592A (en) 1997-10-29 1997-10-29 Methods and pharmaceutical compositions for oral delivery of molecular iodine
PCT/US1998/022720 WO1999021567A1 (en) 1997-10-29 1998-10-27 Pharmaceutical compositions for oral administration of molecular iodine

Publications (1)

Publication Number Publication Date
DK1024815T3 true DK1024815T3 (da) 2003-05-19

Family

ID=25502851

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98954002T DK1024815T3 (da) 1997-10-29 1998-10-27 Farmaceutisk sammensætning til oral administrering af molekylært iod

Country Status (17)

Country Link
US (1) US5885592A (OSRAM)
EP (1) EP1024815B1 (OSRAM)
JP (1) JP4187410B2 (OSRAM)
KR (1) KR100412219B1 (OSRAM)
CN (1) CN1150904C (OSRAM)
AT (1) ATE231725T1 (OSRAM)
AU (1) AU750627B2 (OSRAM)
BR (1) BR9812588A (OSRAM)
CA (1) CA2301503C (OSRAM)
DE (1) DE69811105T2 (OSRAM)
DK (1) DK1024815T3 (OSRAM)
ES (1) ES2191973T3 (OSRAM)
IL (1) IL134778A0 (OSRAM)
NO (1) NO20001673L (OSRAM)
PT (1) PT1024815E (OSRAM)
RU (1) RU2213564C2 (OSRAM)
WO (1) WO1999021567A1 (OSRAM)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248335B1 (en) * 1997-10-29 2001-06-19 Symbollon Corporation Stabilized oral pharmaceutical composition containing iodide and iodate and method
EP1044689A4 (en) * 1998-01-06 2002-07-03 Fujisawa Pharmaceutical Co SOLID IODOPHORE BASED PREPARATIONS AND MANUFACTURING METHOD THEREOF
CN1306444A (zh) 1998-06-19 2001-08-01 奥西比奥公司 具有抗感染和避孕性能的医学装置
US6154672A (en) * 1998-06-22 2000-11-28 Pacesetter, Inc. Method and apparatus for improving the probability of success of defibrillation shocks
GB2395901A (en) * 1999-02-26 2004-06-09 Symbollon Corp Stabilised tablets containing iodide and iodate
PT1195178E (pt) * 2000-10-06 2006-10-31 Dmg Italia Srl Preparacao imunotrofica para o tratamento da hipertrofia adenoamigdalar.
RU2201229C1 (ru) * 2002-03-26 2003-03-27 Миронов Владимир Андреевич Способ оздоровления организма
US8501223B2 (en) * 2003-06-20 2013-08-06 Hill's Pet Nutrition, Inc. Methods for dietary management of cats to avoid hyperthyroidism
BRPI0411712B1 (pt) * 2003-06-20 2015-07-07 Hills Pet Nutrition Inc Composição com iodo reduzido embalada para dieta de felinos para restabelecer a função normal da tireóide
EP2666366B1 (en) * 2006-01-26 2015-03-11 Hill's Pet Nutrition, Inc. Methods and compositions for treating feline hyperthyroidism
US20090269416A1 (en) * 2006-05-12 2009-10-29 Hill's Pet Nutrition , Inc. Compositions and Methods For Preventing or Treating Chronic Renal Failure in Felines With Hyperthyroidism
US8303994B2 (en) * 2006-06-22 2012-11-06 Jack Howard Kessler Method for the eradication of pathogens including S. aureus and antibiotic resistant microbes from the upper respiratory tract of mammals and for inhibiting the activation of immune cells
EP2040565B1 (en) * 2006-07-03 2013-01-02 Hill's Pet Nutrition, Inc. Copositions and methods for preventing or treating cardiovascular diseases in felines with hyperthyroidism
US7943158B2 (en) * 2006-09-07 2011-05-17 BioLargo Life Technologies, Inc Absorbent systems providing antimicrobial activity
US7867510B2 (en) * 2006-09-07 2011-01-11 BioLargo Life Technologies, Inc Material having antimicrobial activity when wet
US20080063560A1 (en) * 2006-09-07 2008-03-13 Biolargo Life Technologies, Incorporated Ground treatment for reducing microbial content
US9414601B2 (en) * 2006-09-07 2016-08-16 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US8226964B2 (en) * 2006-09-07 2012-07-24 Biolargo Life Technologies, Inc. Systems and methods for cleaning liquid carriers related applications data
US8021610B2 (en) * 2006-09-07 2011-09-20 Biolargo Life Technologies, Inc. Systems providing antimicrobial activity to an environment
US8257749B2 (en) * 2007-02-08 2012-09-04 Biolargo Life Technologies, Incorporated Systems providing at least pesticidal activity
WO2009087647A1 (en) * 2008-01-07 2009-07-16 Council Of Scientific & Industrial Research A stabilized iodine-water concentrate formulation useful for protection against iodine deficiency disorders
MX340005B (es) * 2010-04-23 2016-05-18 Univ Nac Autónoma De México Composicion de yodo molecular de uso humano para la prevencion y tratamiento de patologias prostaticas.
CN103561735B (zh) * 2011-05-16 2016-01-20 S·S·别尕里耶夫 具有抗菌、抗溃疡和免疫调节作用的药物制剂
CN102697804B (zh) * 2012-06-07 2014-02-12 维尔信科技（潍坊）有限公司 一种固态分子碘消毒制剂及其制备方法
US10034899B2 (en) * 2013-11-27 2018-07-31 BioPharmX, Inc. Solid oral dosage form for breast symptoms
ES2987484T3 (es) * 2014-02-10 2024-11-15 Fred Hutchinson Cancer Center Tratamiento de ataque cardiaco y lesión isquémica con yoduro de sodio
CN106163577A (zh) * 2014-03-31 2016-11-23 艾欧泰克国际股份有限公司 未络合的碘的稳定组合物以及使用方法
EA031907B1 (ru) * 2016-03-11 2019-03-29 Тимур Хусаинович Измайлов Шашка иодная дымовая
WO2017185060A1 (en) 2016-04-21 2017-10-26 BioPharmX, Inc. Oral iodine dosage form
MX2019000902A (es) 2016-07-21 2020-09-03 I2Pure Corp Desinfectantes topicos emolientes.
CN106727683A (zh) * 2016-12-23 2017-05-31 刘海涛 一种药物制剂在制备治疗幽门螺杆菌感染性疾病的药物中的应用
TW202203900A (zh) * 2020-03-31 2022-02-01 越南商泰明製藥股份有限公司 用於治療癌症、子宮內膜異位症以及癌症或子宮內膜異位症患者的疼痛之二異丙胺化合物以及碘
EP4196094A4 (en) 2020-08-13 2024-11-13 I2Pure Corp. High molecular iodine concentration compositions, pharmaceutical formulations, preparation and uses
WO2024201560A1 (en) * 2023-03-24 2024-10-03 Me.Link Co., Ltd. Iodine containing colloidal liquid composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2540170C3 (de) * 1975-09-10 1979-01-18 Basf Ag, 6700 Ludwigshafen Verwendung von in organischer Lösung hergestelltem Polyvinylpyrrolidon zur Herstellung von stabilen wäßrigen PoIyvinylpyrrolidon-Jod-Lösungen
US4259322A (en) * 1978-03-20 1981-03-31 Helong Lim Method of treatment of tuberculosis
US4187294A (en) * 1978-07-06 1980-02-05 Nihon Nousan Kougyou Co., Ltd. Method for producing eggs containing a high amount of iodinated amino acids
JPS5663919A (en) * 1979-10-29 1981-05-30 Nippon Nousan Kogyo Kk Remedial composition for diabetes
JPS57140723A (en) * 1981-02-25 1982-08-31 Nippon Nousan Kogyo Kk Preventing composition for hyperlipemia due to neutral fat
US4816255A (en) * 1985-07-31 1989-03-28 Ghent William R Treatment of iodine deficiency breast syndrome
US5250304A (en) * 1985-07-31 1993-10-05 Ghent William R Treatment of iodine deficiency diseases
US5171582A (en) * 1985-07-31 1992-12-15 Ghent William R Treatment of iodine deficiency diseases
US5589198A (en) * 1985-07-31 1996-12-31 943038 Ontario, Inc. Treatment of iodine deficiency diseases
US4849237A (en) * 1987-10-30 1989-07-18 Hurst William D Method for sanitizing poultry carcasses in a poultry processing plant utilizing ozonated water
US5629024A (en) * 1994-08-22 1997-05-13 Symbollon Corporation Method of forming an iodine based germicide composition

Also Published As

Publication number Publication date
EP1024815A1 (en) 2000-08-09
ES2191973T3 (es) 2003-09-16
DE69811105D1 (de) 2003-03-06
JP2003510243A (ja) 2003-03-18
JP4187410B2 (ja) 2008-11-26
CN1272789A (zh) 2000-11-08
WO1999021567A1 (en) 1999-05-06
NO20001673L (no) 2000-05-24
DE69811105T2 (de) 2003-11-06
CN1150904C (zh) 2004-05-26
CA2301503C (en) 2005-01-04
IL134778A0 (en) 2001-04-30
AU1122799A (en) 1999-05-17
EP1024815B1 (en) 2003-01-29
PT1024815E (pt) 2003-06-30
NO20001673D0 (no) 2000-03-31
RU2213564C2 (ru) 2003-10-10
AU750627B2 (en) 2002-07-25
KR100412219B1 (ko) 2003-12-24
US5885592A (en) 1999-03-23
CA2301503A1 (en) 1999-05-06
KR20010030861A (ko) 2001-04-16
ATE231725T1 (de) 2003-02-15
BR9812588A (pt) 2000-07-25

Similar Documents

Publication Publication Date Title
DK1024815T3 (da) Farmaceutisk sammensætning til oral administrering af molekylært iod
GR1002097B (en) A process for providing a composition an analgesic in combination with a h1 or h2 receptor blocker proto n pump ihibitor or combination thereof
IL208184A0 (en) Glp-1, and methods for treating diabetes
ATE306266T1 (de) Verbesserte verabreichungstechnik für multiple medikamentengaben
GEP20022784B (en) Celecoxib Composition
NZ262679A (en) Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell
ATE394107T1 (de) Vorbeugung und behandlung von kolonadenom oder kolonmikroadenom mit 6-fluorursodeoxycholsäure
TR200103613T2 (tr) Burun içinden tatbik edilen morfini içeren farmasötik formülasyonlar ve yöntemler.
SI0770384T1 (en) Solid, anhydrous, pharmaceutical compositions for vaginal use
IL149134A0 (en) Pharmaceutical compositions containing tofisopam
EP1007055A4 (en) METHODS OF ADMINISTERING AMIFOSTINE
AU2855099A (en) Remedies for hepatitis
EP1073436A4 (en) IMPROVED METHOD FOR ERADICATION OF HELICOBACTER PYLORI
EP0271151A3 (en) Azumolene dosage form
SE8701077D0 (sv) Pharmaceutical composition
WO1998057626A1 (en) Use of l-arginine or a pharmaceutically acceptable salt thereof for production of drugs for treatment of helicobacter pylori infections
DK1019066T3 (da) Fremgangsmåder og præparater til forebyggelse og behandling af halsbrand
CA2197139A1 (en) A drug for the treatment of cancer
DE69814669D1 (de) Pharmaceutische Zusammensetzung enthaltend (+)-EPHEDRIN und einen H1 Rezeptor Antagonisten
YU28700A (sh) Upotreba potencijatora osetljivosti na insulin u proizvodnji leka za lečenje hiperglikemije
ZA989356B (en) Pharmaceutical preparations
AU8716001A (en) Treatment of hepatitis c with thymosin and pegylated interferon
TW357092B (en) Transport of solid medicament components
UA39418A (uk) Спосіб лікування виразкової хвороби, асоційованої з helicobacter pylori